At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Modafinil in a Human Laboratory Model of Cocaine Relapse
In Brief
A Phase 2 clinical trial evaluating Modafinil 0 mg, Modafinil 200 mg, and 5 other interventions for Cocaine Dependence. Completed, enrolled 8 participants across 1 site.
Detailed Summary
Modafinil has been reported to reduce cocaine use in a clinical sample of infrequent users (2 days/week), but the effects of modafinil on cocaine self-administration in the laboratory have not been studied. The present study investigated the effects of modafinil maintenance on cocaine self-administration by frequent users (4 days/week) under controlled laboratory conditions. During this 48-day double-blind, crossover design study, the effects of modafinil maintenance (0, 200, and 400mg/day) on response to smoked cocaine (0, 12, 25, and 50 mg) were examined in nontreatment seeking cocaine-dependent individuals (n = 8).
Study Details
Timeline
Interventions
Modafinil (0 mg/day)
Modafinil (200 mg/day)
Modafinil (400 mg/day)
Cocaine (0 mg/day)
Cocaine (12 mg/day)
Cocaine (25 mg/day)
Cocaine (50 mg/day)